Neerincx, M http://orcid.org/0000-0002-0146-9375
Sie, D L S
van de Wiel, M A
van Grieken, N C T
Burggraaf, J D
Dekker, H
Eijk, P P
Ylstra, B
Verhoef, C
Meijer, G A
Buffart, T E
Verheul, H M W
Article History
Received: 13 June 2015
Revised: 20 August 2015
Accepted: 27 August 2015
First Online: 5 October 2015
Competing interests
: Honoraria from Roche (CV), consulting or advisory role for Roche (CV). Patents pending (GAM), research funding by public and private partnerships within the context of CTMM (Center for Translational Molecular Medicine) (GAM). The remaining authors declare no conflict of interest.